EXPLORE MORE CATEGORIES
- Home
- »
- Our Products
- »
- Pharmaceutical Books
Pharmaceutical Books
Pioneers in the industry, we offer indian pharmacopoeia 2022, 9th edition, ( only online version available ), martindale: the complete drug reference, 41st edition, 2 volumes sets, japanese pharmacopoeia, 18th edition - english version, ( 2 vols set ), european pharmacopoeia (ph. eur.) 11th edition, ( 3 volumes set ), 2023, rules and guidance for pharmaceutical manufacturers and distributors 2022 ( the mhra orange guide) and strategic pharmaceutical marketing from India.
Indian Pharmacopoeia 2022, 9th Edition, ( Only Online Version Available )
Product Price: Rs 28,000 / SetGet Best Price
Minimum Order Quantity: 1 Set
Product Details:
| Subject/Specialty | Pharmaceutical |
| Edition | 9th Edition 2022 |
| Author | Govt. of India ( IPC ) |
| Book Name | Indian Pharmacopoeia 2022,9th Edition,4 Vols. Set |
| Language | English |
| Name Of Book | Indian Pharmacopoeia 2022, 9th Edition, 4 Vols. Set |
| Published By | IPC |
| ISBN | 1 |
| Color | Orange |
| Binding Type | Online Version |
| Cover | Online Version |
| Standard | Indian |
| Packaging Type | Online Vertsion |
| Product Code | 1 |
| Year | 2022 |
| Brand | Pharmaceutical - Online Version |
| Material | Pharmaceutical - Online Version |
| Country of Origin | Made in India |
Only Online Available
Indian Pharmacopoeia 2022: Published By Indian Pharmacopoeia Commission (IPC)
Effective Date : 1st December 2022 (Tentative)
Salient Features:
◗ New Monographs: 92 APIs: 27 Dosage Forms (Chemicals): 33
◗ Vitamins, Minerals, Amino acids, Fatty Acids etc.: 21
◗ Biotechnology Derived Therapeutic products: 03
◗ Herbs & Herbal Products: 02
◗ Blood & Blood Related Products: 02
◗ Vaccines and Immunosera for human use: 04
◗ New General Chapters: 12
The Indian Pharmacopoeia (IP) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of Ministry of Health & Family Welfare, Government of India to fulfil the requirements of the Drugs and Cosmetics Act 1940. IP prescribes the official standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines. The standards of the IP are authoritative and legally enforceable. It intends to help in the licensing of manufacturing, inspection and distribution of medicines in our country.
IP 2022 contains a total of 92 new monographs including 60 Chemical, 21 Vitamins, Minerals, Amino acids, Fatty acids etc., 3 Biotechnology-derived Therapeutic Products, 4 Human Vaccines, 2 Blood and Blood Related Products, 2 Herbs and Herbal Related Products, and 7 Phytopharmaceutical Ingredient Category monographs. This has led to the total number of 3152 monographs in the current edition of IP. In additions, 12 new general chapters have also been introduced.
Additional Information:
- Delivery Time: Within 7-8 Working days
- Packaging Details: Only Online Version Available
Yes! I am InterestedRequest A Callback
Martindale: The Complete Drug Reference, 41st Edition, 2 Volumes Sets
Product Price: Rs 63,000 / SetGet Best Price
Minimum Order Quantity: 1 Set
Product Details:
| Subject/Specialty | Pharmaceutical / Pharmacy |
| Author | Martindale |
| Edition | 41st Edition |
| Name Of Book | Martindale: The Complete Drug Reference, 41st Edition, 2 Volumes Sets |
| Book Name | Martindale: The Complete Drug Reference,41st Edition,2 Volumes Sets |
| Publishing Year | 2024 |
| Color | Blue |
| Language | English |
| Number of Pages | 4800 Pages |
| Standard | UKP 650.00 |
| Packaging Type | 2 Volumes Set - Hardcover |
| ISBN | 978-085711484-6 |
| Size/Dimension | 520 x 369 x146 mm |
| Weight | 6.78 Kg |
| Material | Printed Pharmaceutical Book |
Martindale: The Complete Drug Reference provides unbiased, evaluated information on drugs and medicines in use around the world. It remains the leading international resource, respected for its objectivity, reliability and global coverage, it's unique offering:
- Includes encyclopaedic facts about drugs and medicines:
- Over 6,600 monographs on drugs and ancillary substances
- Over 200,000 preparations
- Over 60,000 references
- Over 25,000 manufacturers and distributors
- Enables identification of medicines, the local equivalent, and the manufacturer
- Covers herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons
- Evidence-based and extensively referenced
New for the 41st Edition - Over 130 monographs including:
- New antivirals such as fostemsavir and lenacapavir for multi-drug resistant HIV infection and bulevirtide for hepatitis D
- New biological treatments for type 1 diabetes (teplizumab), non-neovascular (dry) age-related macular degeneration (pegcetacoplan), and spinal muscle atrophy type 1 (onasemnogene abeparvovec)
- New class of drugs for migraine management: the calcitonin gene-related peptide (CGRP) receptor antagonists atogepant, rimegepant, ubrogepant, and zavegepant
- New content on management of COVID-19 including a new disease treatment review, COVID-19 infections, new monographs for the antivirals molnupiravir, nirmatrelvir, and remdesivir, and for COVID-19 vaccines, and updates to uses of baricitinib and tocilizumab
- Updated content on malaria and dengue vaccines
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
Japanese Pharmacopoeia, 18th Edition - English Version, ( 2 Vols Set )
Product Price: Rs 67,000 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Subject/Specialty | Pharmaceutical |
| Author | JP |
| Edition | 18th Editiojn |
| Usage/Application | Pharma Industry |
| Language | English |
| Published By | JP |
| Year | 2023 |
| Brand | Pharmaceutical Reference |
| Material | Reference Pharma Book |
The Japanese Pharmacopoeia is the pharmaceutical standard that the Japanese Minister of Health, Labour and Welfare (MHLW) establishes to regulate the properties and quality of drugs.
As with other pharmacopoeias, the document is revised periodically. The 18th edition (JP18) came into effect on June 7, 2021. The text is originally prepared in Japanese and translated to English after the publication of the Japanese version. This usually is done within one year. According to the publication schedule, Supplement I to JP18 is to be published in December 2022 and Supplement II in 2024. It is planned that the 19th edition will be published in 2026.
Content of JP18 English Version
Official Monographs (A to L)
Official Monographs (M to Z)
Crude Drugs and Related Drugs
Infrared Reference Spectra
Ultraviolet-visible Reference Spectra
General Information
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
European Pharmacopoeia (Ph. Eur.) 11th Edition, ( 3 Volumes Set ), 2023
Product Price: Rs 52,500 / SetGet Best Price
Minimum Order Quantity: 1 Set
Product Details:
| Name Of Book | EP : European Pharmacopoeia (Ph. Eur.) 11th Edition, 2023 |
| Language | English |
| Book Name | European Pharmacopoeia (Ph. Eur.) 11th Edition,2023 |
| Published By | EPC |
| Edition | 11th Edition |
| Color | Blue |
| Packaging Type | 3 Volumes Set - Main Volumes 11.0,Supplement 11.1,and Supplement 11.2 |
| Year | 2023 |
| Brand | Pharmaceutical Book - Main Volumes 11.0,Supplement 11.1,and Supplement 11.2 |
| Material | Pharmaceutical Book |
Available to order from July 2022 / Effective from 1 January 2023
The primary source for quality control standardsThe European Pharmacopoeia (Ph. Eur.) is the primary source of official quality standards for medicines and their ingredients in Europe. Ph. Eur. standards provide a scientic basis for the quality control of a product throughout its life cycle, supporting the pharmaceutical industry and healthcare systems.
As laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in European Union and national pharmaceutical legislation, these standards are legally binding. They become mandatory on the same date in all states parties to the convention.
The 11th Edition key facts and figures
- New edition, legally binding in 39 European countries as of 1 January 2023 and applied in more than 130 countries worldwide.
- Continually updated and modernised to meet users' needs.
- The 11th Edition of the Ph. Eur. contains:
- 2 469 monographs (including dosage forms);
- 386 general texts (including general monographs and methods of analysis);
- and more than 2 800 descriptions of reagents.
- Released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).
Print version
- three initial volumes (11.0), followed by eight non-cumulative supplements (11.1 to 11.8);
- available in either English or French;
- now with QR codes for easier linking to the Knowledge database for each monograph and general chapter;
- contains a subscription key (EPID code) giving access to the Ph. Eur. online archives.
Note that the 11th Edition print version will no longer contain change marks in revised and corrected texts.
Additional Information:
- Delivery Time: within 7-8 Working days.
Yes! I am InterestedRequest A Callback
Rules And Guidance For Pharmaceutical Manufacturers And Distributors 2022 ( The Mhra Orange Guide)
Product Price: Rs 8,000 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Subject/Specialty | Pharmacy |
| Edition | 2022 |
| Author | MHRA: Medicines & Healthcare Products Regulatory Agency |
| Book Name | Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2022 (The MHRA Orange Guide) |
| Language | English |
| ISBN | 978-085711439-6 |
| Number Of Pages | 1140 Pages |
| Binding Type | Paperback |
| Size | 244x172mm |
| Cover | Soft Cover |
| Brand | Pharmaceutical Book ( Pub: Pharmaceutical Press ) |
| Material | Pharmaceutical Reference Book |
It provides you with a single authoritative source of European and UK guidance, information and UK legislation relating to the manufacture and distribution of human medicines, active substances, and brokering medicines.
The new 11th edition has been updated to incorporate changes made after the UK’s exit from the European Union on the 31st January 2020.
Comprehensive new content includes:
- Amended extracts from the Human Medicines Regulations 2012 relating to:
- manufacture, importation and assembly
- wholesale dealing
- brokering medicine
- manufacturing, importing and distributing active substances
- The Code of Practice for Qualified Persons, Guidance on Manufacture and Importation
- UK guidance on complying with the EU guidelines on Good Distribution Practice for wholesale distributors and brokers of medicines and manufacturers, importers and distributors or active substances
- UK guidance on: risk-based inspections, conditions of holding a manufacturer’s licence, wholesale dealer’s licence, a broker registration and an active substance registration, and controls on certain medicinal products.
New guidance on:
- conditions of holding a manufacturing authorisation for investigational medicinal products,
- importing guidance for investigational medicinal products from countries on a list to Great Britain,
- Pharmaceutical Quality System expectations and Authorisation requirements for investigational medicinal products importation oversight,
- list of approved countries for import,
- pharmacovigilance for wholesalers,
- the naming of sites on a wholesale dealer’s licence,
- self-inspection for wholesale dealers and the responsible person for import.
Plus, revised GMP Annexes 2 and 17, and Commission guidance on principles and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections, for medicinal products for human use and for active substances for medicinal products for human use.
The MHRA Orange Guide is compiled by the Medicines and Healthcare products Regulatory Agency.
Additional Information:
- Delivery Time: Within 7-8 Working days.
Yes! I am InterestedRequest A Callback
Strategic Pharmaceutical Marketing
Product Price: Rs 356 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Name Of Book | Strategic Pharmaceutical Marketing |
| Author | Raja B. Smarta |
| Language | English |
| Edition | 1st Edition |
| Published By | PharmaMed Press/BSP Books |
| Brand | Reference Book - Pharmaceutical Marketing |
| Color | Gray |
| Pages | 392 pages |
| Year | Rpt. 2021 |
| Packaging Type | Single Book |
| Product Code | 9789352301720 |
| Country of Origin | Made in India |
The pharmaceutical industry today is faced with significant challenges owing to the volatile and competitive business environment. For both survival and growth, it is imperative for pharmaceutical organizations to rethink their way of doing business, especially their marketing.
The book 'Strategic Pharmaceutical Marketing' thus, focuses on the practice of marketing prescription medications. It highlights the political, economical, social, technological and regulatory perspectives of pharmaceutical marketing, examines consumers, prescribers and explores positive marketing, pricing and distribution strategies. It provides a detailed explanation of pharmaceutical marketing as well as provides real-world case studies to demonstrate certain aspects.
The book is scripted from an industry and academic perspective. It allows pharmaceutical marketers to have a detailed understanding of the functions of pharmaceutical marketing thus, helping them plan their marketing strategies in a more accurate and precise way.
Individuals entering the field of marketing pharmaceutical products - sales personnel, assistant product managers, marketing staff as well as policy makers will achieve an in-depth understanding of the pharmaceutical industry. The marketing models described in the book along with promotion, distribution, and pricing scenarios, competitive analysis and market research will benefit the pharmaceutical marketer as a whole.
The book would provoke you to think of the surface and latent problems in new ways, find out different and more imaginative solutions and reflect on different options for tomorrow to scope with the chang ing situations.
The book also deals with pharmaceutical marketing financial analysis to help measure the success of the marketing decisions and return on investment.
This book, written in a reader-friendly style will help the marketers and CEOs of the pharmaceutical industry to bring about synergy in their strategies and operations, by thinking about the options, and looking at innovation as an important ingredient for progress. It will also help to generate cost-effective and new marketing approaches. Professionals in healthcare as also marketing executives in other industries will also find the book useful.
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
Cracking The Generics Code
Product Price: Rs 1,995 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Name Of Book | Cracking the Generics Code |
| Language | English |
| Published By | PharmaMed Press/BSP Books |
| Author | Subba Rao Chaganti |
| Edition | 1st Edition |
| Color | White |
| Packaging Type | Single Book |
| Product Code | 9789390211579 |
| Year | Rpt. 2023 |
| Brand | Reference Book - Pharmaceutical |
| Country of Origin | Made in India |
The global generic drug industry is robust and growing. The total value of the global generic drug industry has crossed $900 billion in 2016, and is poised to cross the coveted $1 trillion soon. However, the generic sector is not very concentrated, with the top ten global generic companies accounting for about only 38 percent of the total value. Furthermore, only four companies — Mylan, Teva, Sandoz, Pfizer (General and Established Products) Generics division, and Sun Pharma, have a truly global presence. Why is it that only four out of the many generic drug companies are global, and the rest are not? What are the success secrets of these companies? Do they have a separate Success DNA? A Code for winning in the global generic drug markets? Can any of the other companies become global?
CRACKING THE GENERICS CODE unravels the mystery of the DNA for success in the international generic drug markets. It, as the title, suggests cracks the code to succeed in the global generic drug markets. The key to the generics code is a synthesis of insights gained from a detailed study of twenty leading players in the business. A detailed analysis of these twenty companies reveals the success code of a winning strategy’s ten essential elements. Therefore, CRACKING THE GENERICS CODE will be your valuable guide for formulating and executing strategies for winning in the global generics markets. The book presents insights gleaned and gained from the strategies employed by these twenty highly successful companies in a capsule form.
Every which way you look at it, CRACKING THE GENERICS CODE is your single-source success manual for winning at multi-source (generic drugs) product markets!
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
What Everyone should know about Medicines
Product Price: Rs 536 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Name Of Book | What Everyone should know about Medicines |
| Author | Guru Prasad Mohanta |
| Language | English |
| Edition | 2nd Edition |
| Published By | PharmaMed Press/BSP Books |
| Brand | Reference Book - Pharmaceutical |
| Color | Yellow |
| Pages | 414 pages |
| Packaging Type | Single Book |
| Product Code | 9789387593985 |
| Country of Origin | Made in India |
Medicines are perhaps the greatest weapons of the mankind to fight diseases and death, but are double edged weapons. They help recovering from illness and restoring health if used properly; but can harm if not used appropriately, even causing life threatening situations including death. Inappropriate medicine use is unnecessary wastage of resources. Medicines have helped increasing life expectancy but in some situations they have harmed too. The antibiotics are becoming increasingly ineffective due resistance developed by random use. The book provides guidance on using medicines appropriately in a simple and easily understandable language.
The book intends to empower the readers with skill and knowledge to make informed decisions about how to use medicines (including when not to use them) and get the maximum benefit. It helps to understand the importance of medicines inindividual’s health. The second edition of the book is updated with the new information on medicines as available. Many new themes are introduced with value addition like cartoons.
It is a comprehensive medicine user guide for common public. A must for every one!
Additional Information:
- Delivery Time: #Within 7-8 Working days.
Yes! I am InterestedRequest A Callback
Medicomarketing Writing: A Career for Health Science Students
Product Price: Rs 315 / PieceGet Best Price
Product Details:
| Author | Viswanatha & Anusuya D |
| Language | English |
| Edition | 1st Edition |
| Published By | PharmaMed Press |
| Brand | Reference Book - Pharma |
| Book Name | Medicomarketing Writing: A Career for Health Science Students |
| Color | Blue |
| Pages | 213 Pages |
| Year | Rpt. 2019 |
| Packaging Type | Single Copy |
| Product Code | 9789352300860 |
| Material | Pharmaceutical Book |
| Country of Origin | Made in India |
Medical writing is part of drug development process. Medicomarketing writing is a type of medical writing where scientific information is presented as promotional literatures. Medicomarketing communication or healthcare communication has evolved as a profession over a decade. More and more pharmaceutical industries are outsourcing their work to medicomarketing communication or healthcare communication companies and freelance medical writers.
The skills required for medicomarketing writing are different from the skills required for any other profession. With more than 15 years of experience in medicomarketing communication segment, we have identified the skills required for medicomarketing writing and the lack of skill among the pharmacists, doctors and life science graduates, who have the ability to excel in medical writing. This is the first book, which gives practical insights into medicomarketing writing.
This book is ideal for graduates and postgraduates in Pharmacy, Medicine, Dentistry and Life science
This book is also useful for
Newbie medicomarketing writers
Product managers and medical advisors working in pharmaceutical companies
Senior medical writers working in publishing companies
Team leaders and project managers working in medical communication and medical advertising agencies
Freelance medical writers
Additional Information:
- Delivery Time: Within 7-8 Working Days.
Yes! I am InterestedRequest A Callback
Compete or Forfeit
Product Price: Rs 625 / PieceGet Best Price
Product Details:
| Name Of Book | Compete or Forfeit |
| Author | Subba Rao Chaganti |
| Edition | 1st Edition |
| Color | Brown |
| Pages | 387 pages |
| Year | Rpt. 2007 |
| Packaging Type | Single Book |
| Product Code | 8188449261 |
| Country of Origin | Made in India |
The pharmaceutical world is not flat. Only three regions - (North America, Western Europe and Japan), which inhabit a mere 13 per cent of population account for over 80 per cent of world pharmaceutical market. This is however changing mainly due to the rapid genericization driven by the winds of declining R&D productivity, vanishing market exclusivities consequent to patent expiries, and ever-increasing efforts by virtually every government on earth to contain healthcare costs.
Compete or Forfeit is the story of a small bunch of flatteners (about a dozen) and eighteen other firms who are followers or early adopters of these flatteners from India, who are determined to level the pharmaceutical world by creating world-class technological and manufacturing infrastructure and research and development capabilities. While these champion-entrepreneurs originate from the Indian sub-continent, their strategic vision and game plans are not restricted to any one nation or region and therefore, all the elements of their strategies are applicable to all aspiring companies who want to enhance their competitiveness and are raring to compete, wherever they are situated be it China, Latin America, CEE, Africa, Russia or Asia.
Compete or Forfeit offers very valuable insights into what can be done and more importantly how it can be done by showing how these thirty companies discussed in the book have accomplished in a tough, ruthless and unforgiving market place that demands nothing but the best and how they are converting entry barriers into gateways to the remunerative first world markets. These companies already account for:
- Over 80 per cent of all ANDAs and DMFs filed by Indian companies in the US, the largest generic market in the world
- Over 90 per cent of all acquisitions made by Indian Pharma companies overseas
- Over 75 per cent of all exports of APIs, and FDFs from India
- The maximum number of US FDA inspected facilities outside the US
To Develop World Class capabilities in todays hyper competitive world is no longer a matter of choice. It is rather mandatory.Remember if you are not competing you are forfeiting an opportunity to succeed.
Additional Information:
- Delivery Time: Within 7-8 Working Days
Yes! I am InterestedRequest A Callback
Addendum 2024 to Indian Pharmacopoeia 2022
Product Price: Rs 7,500 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Subject/Specialty | Pharmaceutical |
| Author | IPC |
| Edition | 2024 Edition |
| Name Of Book | Addendum 2024 to Indian Pharmacopoeia 2022 |
| Language | English |
| Book Name | Addendum 2024 to Indian Pharmacopoeia 2022 |
| Published By | Indian Pharmacopoeia Commission |
| Color | Light Orange |
| Standard | Indian Pharmacopoeia |
| Packaging Type | Single |
| Year | 2024 |
| Brand | Indian Pharmacopoeia |
| Material | Book - Hardcover |
| Country of Origin | Made in India |
Contents of Addendum 2024
The Addendum comprises a noteworthy:
- 75 new drug monographs,
- Encompassing Pharmaceuticals,
- Veterinary Pharmaceuticals,
- Phytopharmaceuticals, and
- Biotechnology-Derived Therapeutic Products.
Additionally, it introduces 9 new General Chapters and General Monographs, covering various categories such as:
- Pharmaceuticals,
- Veterinary Biological Products,
- Bacterial Endotoxins, and
- Phytopharmaceuticals.
Furthermore, a total of 220 monographs have undergone revisions, including:
- Pharmaceuticals,
- Vitamins,
- Minerals,
- Amino Acids,
- Veterinary Pharmaceuticals,
- Phytopharmaceuticals,
- Biotechnology-Derived Therapeutic Products,
- Vaccines and Immunosera for Human Use,
- Blood and Blood-Related Products, and
- Changes in titles.
This extensive revision involves:
- 158 Pharmaceuticals,
- 22 Vitamins, Minerals, Amino Acids, Fatty Acids etc.,
- 21 Veterinary Pharmaceuticals,
- 1 Phytopharmaceutical,
- 5 Biotechnology Derived Therapeutic Products,
- 4 Vaccines and Immunosera for Human Use,
- 6 Blood and Blood-Related Products, and
- 3 changes in titles.
Additionally, 21 General Chapters and General Monographs have undergone revisions in the IP Addendum 2024.
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
British National Formulary : BNF 87 March - September 2024
Product Price: Rs 8,550 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Subject/Specialty | PHarmaceuticals |
| Author | BNF |
| Edition | 1st Edition : March - September 2024 |
| Name Of Book | British National Formulary : BNF 87 March - September 2024 |
| Published By | Pharmaceutical Book |
| Publishing Year | 2024 |
| Color | Light Purple |
| Language | English |
| Number of Pages | 1904 Pages |
| Standard | UK Po 79.00 |
| Packaging Type | Single Book - Paperback |
| ISBN | 978-085711480-8 |
| Size/Dimension | 210 x 148 mm |
| Weight | 1 kg 90 g |
| Material | Printed Pharmaceutical Book |
An integral part of the UK’s healthcare infrastructure and relied on by health professionals who prescribe, dispense, and administer medicines globally. Containing guidance on best practice in prescribing, as well as legal and ethical considerations, BNF supports safe and effective decision-making at the point of care.
Published jointly by BMJ Publishing Group Ltd and Royal Pharmaceutical Society
Extensive content updates in the BNF 87 edition include:
New monographs for:
- Aquipta ® [atogepant] for prophylaxis of migraine
- Filsuvez ® [birch bark extract] to promote wound healing
- Omvoh ® [mirikizumab] for ulcerative colitis
- Qdenga ® [dengue vaccine] for immunisation against dengue virus infection
- Quviviq ® [daridorexant] for insomnia
- Roclanda ® [latanoprost with netarsudil] for ocular hypertension and raised intra-ocular pressure in open-angle glaucoma
- Sotyktu ® [deucravacitinib] for plaque psoriasis
- Vaxchora ® [cholera vaccine (live)] for immunisation against cholera
MHRA advice on:
- Calcium chloride, calcium gluconate: potential risk of underdosing with calcium gluconate in severe hyperkalaemia
- Direct-acting oral anticoagulants: reminder of dose adjustments in patients with renal impairment
- Febuxostat: updated advice for the treatment of patients with a history of major cardiovascular disease
- Hyoscine hydrobromide patches (Scopoderm ®): risk of anticholinergic side effects, including hyperthermia
- Isotretinoin (Roaccutane ®): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age
- Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality
- Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions
- Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions
- Non-steroidal anti-inflammatory drugs: potential risks following prolonged use after 20 weeks of pregnancy
- Quinolones: reminder of the risk of disabling and potentially long-lasting or irreversible side effects, risk of suicidal thoughts and behaviour
- Statins: very infrequent reports of myasthenia gravis
- Valproate: full pack dispensing, re-analysis of study on risks in children of men taking valproate, reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
European Pharmacopoeia Supplements 11.3 to 11.5 - 2024
Product Price: Rs 52,500 / SetGet Best Price
Minimum Order Quantity: 1 Set
Product Details:
| Language | English |
| Book Name | European Pharmacopoeia Supplements 11.3 to 11.5 - 2024 |
| Published By | EPC |
| Edition | 11th Edition |
| Color | Blue |
| Standard | Three Supplements 11.3, 11.4 and 11.5 |
| Packaging Type | Set of 3 Supplements 11.3, 11.4 and 11.5 |
| Product Code | 978-928719268-4 |
| Year | 2023. |
| Brand | Pharmaceutical / Pharmacy Books |
| Material | Pharmaceutical Book ( Supplements 11.3, 11.4 & 11.5 ) |
The European Pharmacopoeia (Ph. Eur.), including the Supplements 11.3 to 11.5, are now available in Print Version, of the European Directorate for the Quality of Medicines & HealthCare (EDQM).
Print Version :
Three non-cumulative updates in Supplements 11.3, 11.4 and 11.5.
Main volume 11.3 Published in July 2023, Implemented - January 2024
Supplement 11.4 Published in October 2023, Implemented - April 2024
Supplement 11.5 Published in January 2024, Implemented - July 2024
The European Pharmacopoeia (Ph. Eur.) is the primary source of official quality standards for medicines and their ingredients in Europe. Ph. Eur. standards provide a scientific basis for the quality control of a product throughout its life cycle, supporting the pharmaceutical industry and healthcare systems.
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
European Pharmacopoeia Supplements 11.6 to 11.8 - 2025
Product Price: Rs 52,500 / SetGet Best Price
Minimum Order Quantity: 1 Set
Product Details:
| Subject/Specialty | Pharmaceuticals |
| Author | EP |
| Edition | 11th Edition |
| Name Of Book | European Pharmacopoeia Supplements 11.6 to 11.8 - 2025 |
| Published By | Pharmacopoeia European Pharmacopoeia Comission |
| Publishing Year | 2024 |
| Color | Blue |
| Language | English |
| Packaging Type | 3 Volumes Set - Supplements 11.6, 11.7 & 11.8 |
| Size/Dimension | A4 (210 x 297 mm) |
| Weight | 10.0 kg |
| Brand | Medical / Pharmaceutical Book |
| Material | Printed Pharmaceutical Book |
The European Pharmacopoeia (Ph. Eur.), including the Supplements 11.6 to 11.8, are now available in Print Version, of the European Directorate for the Quality of Medicines & HealthCare (EDQM).
Print Version :
Three non-cumulative updates in Supplements 11.6, 11.7 and 11.8.
Main volume 11.6 Published in July 2024, Implemented - January 2025
Supplement 11.7 Published in October 2024, Implemented - April 2025
Supplement 11.8 Published in January 2025, Implemented - July 2025
The European Pharmacopoeia (Ph. Eur.) is the primary source of official quality standards for medicines and their ingredients in Europe. Ph. Eur. standards provide a scientific basis for the quality control of a product throughout its life cycle, supporting the pharmaceutical industry and healthcare systems.
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
European Pharmacopoeia - New online-only, 12th Edition (EP)
Product Price: Rs 63,450 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Subject/Specialty | Pharmaveutuicals |
| Author | European Pharmacopoeia Commission (EPC) |
| Edition | 12th Edition |
| Book Name | European Pharmacopoeia - New online-only, 12th Edition (EP) |
| Language | English |
| Brand | Pharmacopoeia - 12th Edition - Online Only |
| Material | European Pharmacopoeia - Online Version - Only |
| Published By | European Pharmacopoeia Commission (EPC) |
| Name Of Book | European Pharmacopoeia - New online-only, 12th Edition (EP) |
The primary source for quality control standards
The European Pharmacopoeia (Ph. Eur.) is the primary source of official quality standards for medicines and their ingredients in Europe. Ph. Eur. standards provide a legal and scientific basis for the quality control of a product throughout its life cycle, supporting the pharmaceutical industry and healthcare systems.
As laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in European Union and national pharmaceutical legislation, these standards are legally binding. All producers of pharmaceuticals must therefore apply them in order to market their products in the signatory states of the Convention.
Order a 365-day access licence and stay connected with the Ph. Eur.
As of the 12th Edition, the Ph. Eur. will be available in an online-only format.
The previous three-year cycle, which included one edition and eight supplements, is being replaced by an annual edition consisting of three issues. The 12th Edition is therefore composed of Issues 12.1, 12.2, and 12.3. Each issue will contain new and revised texts adopted at one of the three European Pharmacopoeia Commission (EPC) sessions held annually.
The licence model has also been switched to a user-friendly 365-day licence.
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
Kidney Transplantation, 9th Edition, 2025
Product Price: Rs 16,799 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Subject/Specialty | Transplant Surgery |
| Author | Stuart J. Knechtle |
| Edition | 9th Edition |
| Book Name | Kidney Transplantation, 9th Edition |
| Language | English |
| Brand | Medical Book - Transplant Surgery |
| Material | Printed Medical Book |
| Name Of Book | Kidney Transplantation, 9th Edition |
A must-have resource for all members of the transplant team, Kidney Transplantation: Principles and Practice, 9th Edition, provides comprehensive, up-to-date information on every aspect of this complex field. Drs. Stuart J. Knechtle and Lorna P. Marson, along with a global team of internationally renowned surgeons and nephrologists, offer balanced coverage of both surgical techniques and medical considerations related to kidney transplantation. With updates from cover to cover, this core reference delivers the practical guidance you need to achieve optimal outcomes in both adults and children.
Key Features
Offers state-of-the-art coverage of all areas of kidney transplantation such as preservation of kidneys; mechanisms of rejection and the induction of tolerance; techniques of laparoscopic live donor nephrectomy; and immunosuppression
Contains up-to-date outcomes data and analysis of the evidence supporting current practice in the field
Includes new chapters on xenotransplantation and COVID-19 in renal transplantation
Adds new information on normothermic regional perfusion to the discussion of DCD organ donation and ethics of transplantation, and new information on iBox (the first universal algorithm for predicting the risk of kidney transplant loss) to the biomarkers section
Provides relevant, up-to-date information on kidney transplant for all members of the transplant team, with practical information on applied science, clinical information, and surgical procedures
Features intraoperative videos and hundreds of superb illustrations to help readers visualize key concepts and nuances of renal transplantation
Covers each major immunosuppressive drug in individual chapters, and provides a reference list of all randomized trials for convenient access to critical information
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
Author Information
Edited by Stuart J. Knechtle, MD, FACS, William R. Kenan, Jr. Professor of Surgery; Executive Director, Duke Transplant Center; Duke University School of Medicine, Durham, North Carolina, USA; Lorna P. Marson, MD, FRSE, Professor of Transplant Surgery, University of Edinburgh and Honorary Consultant Transplant Surgeon, Royal Infirmary of Edinburgh, UK
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
Digital Pharma Marketing Playbook
Product Price: Rs 2,495 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Name Of Book | Digital Pharma Marketing Playbook |
| Author | Subba Rao Chaganti |
| Language | English |
| Edition | 1st Edition |
| Published By | PharmaMed Press/BSP Books |
| Brand | Reference Book - Pharmaceutical |
| Color | White |
| Pages | 741 pages |
| Year | Rpt. 2023 |
| Packaging Type | Single Book |
| Product Code | 9789389354478 |
Additional Information:
- Delivery Time: Within 7-8 Working Days
Yes! I am InterestedRequest A Callback
Bullseyes and Blunders: Lessons from 100 Cases in Pharmaceutical Marketing
Product Price: Rs 2,065 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Name Of Book | Bullseyes and Blunders: Lessons from 100 Cases in Pharmaceutical Marketing |
| Author | Subba Rao Chaganti |
| Language | English |
| Edition | 1st Edition |
| Published By | PharmaMed Press/BSP Books |
| Brand | Reference Book - Pharmaceutical |
| Color | White and Blue |
| Pages | 619 pages |
| Year | Rpt. 2023 |
| Packaging Type | Single Book |
| Product Code | 9789388305440 |
Bullseyes and Blunders: Lessons from 100 Cases in Pharmaceutical Marketing is a first-of-its-kind of a book. The book is an invaluable resource for the practitioners as well as the students of pharmaceutical marketing. The case studies presented in the book offer many experiential insights into how some of the world’s renowned pharmaceutical marketers built, launched, defended and managed their brands and steered them clear of competition. The Bullseyes in the book present a snapshot of these winning brands.
Studying the Blunders or failures or flops too is significant for the practitioners and students of marketing alike. Because these provide the much-needed insights into the essential, Don’ts while building and managing their brands.
Bullseyes and Blunders provides a more practical understanding of various topics that are highly relevant for the Pharma brand managers and marketing managers. These are market opportunity analysis, product positioning, product launches, life cycle management, building and defending a disease-franchise among others.
About the Author:
Subba Rao Chaganti Has a masters in business administration and over fifty-two years of experience in pharmaceutical marketing covering the whole gamut and all facets of the industry from selling to sales management, product management to heading the total marketing activity. His experience includes domestic and international marketing, and also Indian and multinational sectors.
He also taught for a few years a course on Advertising and Brand Management at Gitam Institute of Foreign Trade (now part of Gitam University) at Visakhapatnam as an adjunct professor and also taught a class on Marketing at Jawaharlal Nehru Technological University (JNTU) School of Management, Hyderabad as a visiting faculty.
Here is a list of his publications:
Books Published:
- Pharmaceutical marketing in India: Concepts, Cases, Strategy
- Game Plans for Post-Gatt Era: Action Agenda of Indian Pharmaceutical Industry
- Compete or Forfeit: Strategies for Sustainable Competitive Advantage in Pharma Product Patents Era
- Pharmaceutical Marketing in India for Today and Tomorrow - 25th Anniversary Edition
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback
Pharmaceutical Marketing in India: For Today and Tomorrow
Product Price: Rs 715 / PieceGet Best Price
Minimum Order Quantity: 1 Piece
Product Details:
| Name Of Book | Pharmaceutical Marketing in India: For Today and Tomorrow |
| Language | English |
| Published By | Pharmaceutical Marketing in India: For Today and Tomorrow |
| Author | Subba Rao Chaganti |
| Edition | 1st Edition |
| Color | White & Red |
| Pages | 666 pages |
| Packaging Type | Single Book |
| Product Code | 978-938759385-5 |
| Year | Rpt. 2022 |
| Brand | Reference Book - Pharmaceutical |
| Country of Origin | Made in India |
Twenty-five years ago, Pharmaceutical Marketing in India: Concepts, Cases, Strategy was the first-ever sectoral marketing book in the Asia Pacific Region. Today, twenty-five years later, Pharmaceutical Marketing in India for Today and Tomorrow continues to be the most comprehensive sectoral marketing book in pharmaceuticals in the Asia Pacific Region.
The new 25th Anniversary Edition of the book is an updated version of the original text with significant new content. The seventy-seven cases in the book show how some of the highly successful practitioners of Pharma marketing in India have positioned their products, launched and promoted their brands and defended their therapeutic segments. The experiential insights these cases provide are immensely useful for both the practitioners as well as the students of pharmaceutical marketing in India.
What is new in this all-new 25th Anniversary edition? The book presents an introduction to all aspects of changes and initiatives that are happening in the first world markets and whatever baby steps that are being taken by Indian drug majors and their MNC counterparts in India. To name a few - changing detailing practices such as e-Detailing, iPad detailing or tablet detailing, digital marketing strategies, social media strategies for the pharmaceutical industry, multichannel marketing, closed-loop marketing among others.
The new ways of engaging and building meaningful relationships with physicians in today’s declining physician access scenario are medical sales liaisons (MSL), key opinion leader (KOL) management and key account management (KAM). This latest edition includes these. The primary purpose of this edition is to make it not only relevant for today but also for tomorrow. In other words, to make it as future-proof as is possible.
About the Author:
Subba Rao Chaganti, has a masters in business administration and over fifty-two years of experience in pharmaceutical marketing covering the whole gamut and all facets of the industry from selling to sales management, product management to heading the total marketing activity. His experience covers domestic and international marketing, and also Indian and multinational sectors. He also taught for a few years a course on Advertising and Brand Management at Gitam Institute of Foreign Trade (now part of Gitam University) at Visakhapatnam as an adjunct professor and also taught a course on Marketing at the School of Management, Jawaharlal Nehru Technological University (JNTU), Hyderabad as a visiting faculty.
Here is a list of his publications:
- Pharmaceutical marketing in India: Concepts, Cases, Strategy
- Game Plans for Post-GATT Era: Action Agenda of Indian Pharmaceutical Industry
- Compete or Forfeit: Strategies for Sustainable Competitive Advantage in Pharma Product Patents Era
Additional Information:
- Delivery Time: Within 7-8 Working days
Yes! I am InterestedRequest A Callback